PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19

Daniel Rojas-Bolivar; Fabiola Huaroto-Ramírez; Maricela Curisinche-Rojas; Diana Gonzales Zurita; Ericson Gutiérrez

doi:10.25176/RFMH.v22i3.5009

PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19

Daniel Rojas-Bolivar, Fabiola Huaroto-Ramírez, Maricela Curisinche-Rojas, Diana Gonzales Zurita, Ericson Gutiérrez

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.

Translated title of the contribution	PREVALENCIA, MANIFESTACIONES CLÍNICAS Y FACTORES ASOCIADOS AL COVID-19 DE LARGA DURACIÓN
Original language	English
Pages (from-to)	556-567
Number of pages	12
Journal	Revista de la Facultad de Medicina Humana
Volume	22
Issue number	3
DOIs	https://doi.org/10.25176/RFMH.v22i3.5009
State	Published - 1 Jul 2022
Externally published	Yes

Keywords

COVID-19
Long COVID-19
Post-acute COVID-19 syndrome

Access to Document

10.25176/RFMH.v22i3.5009

Cite this

@article{30460a871a604531877b40e85003d65a,

title = "PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19",

abstract = "Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.",

keywords = "COVID-19, Long COVID-19, Post-acute COVID-19 syndrome",

author = "Daniel Rojas-Bolivar and Fabiola Huaroto-Ram{\'i}rez and Maricela Curisinche-Rojas and Zurita, {Diana Gonzales} and Ericson Guti{\'e}rrez",

year = "2022",

month = jul,

day = "1",

doi = "10.25176/RFMH.v22i3.5009",

language = "Ingl{\'e}s",

volume = "22",

pages = "556--567",

journal = "Revista de la Facultad de Medicina Humana",

issn = "1814-5469",

publisher = "Universidad Ricardo Palma, Instituto de Investigaciones en Ciencias Biomedicas, Facultad de Medicina Humana",

number = "3",

}

TY - JOUR

T1 - PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19

AU - Rojas-Bolivar, Daniel

AU - Huaroto-Ramírez, Fabiola

AU - Curisinche-Rojas, Maricela

AU - Zurita, Diana Gonzales

AU - Gutiérrez, Ericson

PY - 2022/7/1

Y1 - 2022/7/1

N2 - Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.

AB - Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.

KW - COVID-19

KW - Long COVID-19

KW - Post-acute COVID-19 syndrome

UR - http://www.scopus.com/inward/record.url?scp=85168286947&partnerID=8YFLogxK

U2 - 10.25176/RFMH.v22i3.5009

DO - 10.25176/RFMH.v22i3.5009

M3 - Artículo de revisión

AN - SCOPUS:85168286947

SN - 1814-5469

VL - 22

SP - 556

EP - 567

JO - Revista de la Facultad de Medicina Humana

JF - Revista de la Facultad de Medicina Humana

IS - 3

ER -

PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this